Back to search

Article

GLP-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease

2026-02-25

Abstract excerpt

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed the management of type 2 diabetes and obesity, yet their actions extend beyond glycemic control and weight loss. Accumulating evidence indicates that GLP-1 physiology is closely coupled to circadian timing systems and sleep–wake regulation. In this narrative review, we synthesize emerging data that reframe GLP-1RAs as chronometabolic modulators,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9e090db4-fac1-5817-8549-281f1a822242
DOI
10.20944/preprints202602.1433.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GLP-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic DiseaseDOI 10.20944/preprints202602.1433.v1
Circadian Rhythms, Metabolism, and Chrononutrition in Rodents and Humans.Semantic proximity
Chrono-Nutrition: Circadian Rhythm and Personalized NutritionSemantic proximity
Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan.Semantic proximity
Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight lossSemantic proximity
Circadian clocks and metabolism.Semantic proximity
Insulin/IGF-1 Drives PERIOD Synthesis to Entrain Circadian Rhythms with Feeding TimeSemantic proximity
Time-of-day defines the efficacy of NAD <sup>+</sup> to treat diet-induced metabolic disease by adjusting oscillations of the hepatic circadian clockSemantic proximity
The Roles of Incretin Hormones GIP and GLP-1 in Metabolic and Cardiovascular Health: A Comprehensive ReviewSemantic proximity
GLP-1-mediated delivery of the PPAR𝛼/𝛾 dual-agonist Tesaglitazar improves obesity and glucose metabolism in miceSemantic proximity
Pharmacogenomics of GLP-1 Receptor Agonists: Precision Medicine in the Age of Ozempic and MounjaroSemantic proximity
PPARs in Rhythmic Metabolic Regulation and Implications in Health and DiseaseSemantic proximity
Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotypingSemantic proximity
Select a neighboring publication to make it the new centre.